Adjuvant therapy with agonistic antibodies to CD134 (OX40) increases local control after surgical or radiation therapy of cancer in mice

Michael J. Gough, Marka R. Crittenden, Maryclare Sarff, Puiyi Pang, Steven K. Seung, John T. Vetto, Hong Ming Hu, William L. Redmond, John Holland, Andrew D. Weinberg

Research output: Contribution to journal › Article › peer-review

133 Scopus citations

Fingerprint

Dive into the research topics of 'Adjuvant therapy with agonistic antibodies to CD134 (OX40) increases local control after surgical or radiation therapy of cancer in mice'. Together they form a unique fingerprint.

Medicine & Life Sciences